Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 19 252 sessions, August 5, 2022 to August 7, 2023
- Largest daily move
- +205.4% close of April 27, 2023
- 1-year change
- +175.8% closing prices, August 5, 2022 to August 7, 2023
- 5-year change
- +99.6% closing prices, August 7, 2018 to August 7, 2023
Company Description
Polydex Pharmaceuticals (OTC: POLXF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.8M.
POLXF has gained 175.8% over the past year. The last closing price was $1.99.
This page collects what Stock Titan holds for POLXF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Polydex Pharmaceuticals (POLXF) closed at $1.99 on August 7, 2023. Over the past 12 months, the price has gained 175.8%.
POLXF Metrics & Rankings
Price returns through August 7, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Polydex Pharmaceuticals has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all POLXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
POLXF Company Profile & Sector Positioning
Polydex Pharmaceuticals (POLXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing POLXF often look at related companies in the same sector, including AIM ImmunoTech Inc. (AIM), PharmaCyte Biotech, Inc. (PMCB), Cardio Diagnostics Holdings Inc. (CDIO), CERO TERAPEUTICS HLDG INC (CERO), and Artelo Biosciences, Inc. (ARTL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POLXF's relative position within its industry.